1,3-ditolylguanidine has been researched along with Brain Injuries in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abate, C; Berardi, F; Moritz, C; Peri, F | 1 |
De La Cruz-López, F; Flores, G; Garcés-Ramírez, L; González-Elizalde, K; Jaramillo-Loranca, BE; Luna Ramírez, C; Morales-Dionisio, O; Munguía Rosales, AA; Vargas Hernández, G; Zamudio, S | 1 |
2 other study(ies) available for 1,3-ditolylguanidine and Brain Injuries
Article | Year |
---|---|
Live imaging reveals a new role for the sigma-1 (σ1) receptor in allowing microglia to leave brain injuries.
Topics: Animals; Animals, Genetically Modified; Brain Injuries; Cell Movement; Embryo, Nonmammalian; Guanidines; Microglia; Microscopy, Confocal; Piperidines; Receptors, sigma; Tetrahydronaphthalenes; Zebrafish | 2015 |
The sigma agonist 1,3-di-o-tolyl-guanidine reduces the morphological and behavioral changes induced by neonatal ventral hippocampus lesion in rats.
Topics: Analysis of Variance; Animals; Animals, Newborn; Anticonvulsants; Behavior, Animal; Brain Injuries; Exploratory Behavior; Guanidines; Hippocampus; Male; Motor Activity; Prepulse Inhibition; Rats; Rats, Sprague-Dawley; Reflex, Startle; Silver Staining | 2015 |